📈 Fed's first cut since 2020: Time to buy the dip? See Tech-focused stock picksUnlock AI Picks

UPDATE 2-European stock rally halts as coronavirus restrictions weigh

Published 17-11-2020, 02:52 pm
© Reuters
EZJ
-
DBKGn
-
BBVA
-
SABE
-
IMB
-
PFE
-
STOXX
-
SX6P
-
SXEP
-
SX7P
-
SXAP
-
SXDP
-
SXTP
-
MRNA
-

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)

* Travel stocks fall on tighter movement restrictions

* Spain's BBVA slips on news of merger with Sabadell

* Intermediate Cap surges after strong results (Updates prices, adds comment)

By Sruthi Shankar and Shashank Nayar

Nov 17 (Reuters) - European stocks slipped from eight-month highs on Tuesday, as tighter coronavirus restrictions across the continent raised doubts about a swift economic rebound and countered optimism about a COVID-19 vaccine.

The pan-European STOXX 600 .STOXX ended 0.2% lower. The index jumped over 1% to close at its highest level since late February on Monday following positive data about drugmaker Moderna 's MRNA.O COVID-19 vaccine.

Pfizer (NYSE:PFE) and partner BioNTech flagged strong progress in their COVID-19 vaccine last week, sparking a rally in global equities.

"Euphoria is understandable, but unsustainable," strategists at French bank Societe Generale (PA:SOGN) wrote in a note. "The surge of COVID cases in the US and Europe's second lockdown guarantee global economic weakness for several more months."

Many European countries have imposed curbs to fight a resurgence in virus cases. Sweden moved to restrict the size of public gatherings and a British medical adviser suggested strengthening the three-tier system of restrictions when the full lockdown in England ends. stocks .SXTP fell 1.1%, with British airline EasyJet EZJ.L down 1.9% after it recorded a 1.27 billion pound ($1.68 billion) annual loss, the first in its history as the pandemic ravaged the travel industry. .SXDP and tech .SX8P sectors that have outperformed the broader market during the pandemic declined 1.3% and 0.6% respectively.

Meanwhile, growth-linked cyclical sectors such as oil and gas .SXEP and automakers .SXAP reversed early losses and jumped 0.7% as investors bet progress in the development of a COVID-19 vaccine will support the battered sectors.

"The vaccine news eliminates downside risks but is more likely to trigger a rotation than an outright risk rally. We think cyclicals are set to outperform in this rotation," said TS Lombard's Oliver Brennan.

However, banks came under pressure as Spain's BBVA BBVA.MC fell 4.4% after it and smaller rival Sabadell SABE.MC said they were in talks to create the country's second-biggest domestic lender by assets. jumped 6.8%.

British asset manager Intermediate Capital Group ICP.L surged 7.9% to the top of the STOXX 600 after reporting strong half yearly results. company Imperial Brands IMB.L jumped 7.3% after it forecast a rise in profit for 2021, helped by expected improvements in its e-cigarette business.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.